Dysregulation of the cGAS–STING pathway has been implicated in ovarian cancer, where alterations in DNA repair mechanisms and genomic instability can lead to the accumulation of ssDNA, activating the cGAS–STING pathway [24,25]. This evidence concerns the gene STING1 and ovarian cancer.